Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insecticides | 3 | 2022 | 29 | 1.640 |
Why?
|
| Linoleic Acids, Conjugated | 4 | 2008 | 7 | 1.100 |
Why?
|
| Adipogenesis | 2 | 2014 | 71 | 0.830 |
Why?
|
| Obesity | 3 | 2022 | 1186 | 0.820 |
Why?
|
| Caenorhabditis elegans | 2 | 2019 | 618 | 0.790 |
Why?
|
| Adipocytes | 2 | 2014 | 252 | 0.740 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 91 | 0.720 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 9 | 0.670 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 5 | 0.660 |
Why?
|
| Fats | 1 | 2019 | 18 | 0.660 |
Why?
|
| Cell Membrane | 1 | 2022 | 492 | 0.650 |
Why?
|
| Food | 1 | 2017 | 80 | 0.560 |
Why?
|
| Models, Animal | 1 | 2017 | 221 | 0.560 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 674 | 0.480 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2019 | 396 | 0.470 |
Why?
|
| Permethrin | 1 | 2014 | 4 | 0.470 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2014 | 84 | 0.440 |
Why?
|
| Body Weight | 4 | 2008 | 378 | 0.430 |
Why?
|
| Nitro Compounds | 1 | 2012 | 15 | 0.420 |
Why?
|
| Body Composition | 3 | 2008 | 154 | 0.410 |
Why?
|
| Imidazoles | 1 | 2012 | 83 | 0.410 |
Why?
|
| Aging | 1 | 2017 | 723 | 0.390 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 551 | 0.380 |
Why?
|
| Insulin Resistance | 1 | 2014 | 404 | 0.360 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 43 | 0.300 |
Why?
|
| Anti-Obesity Agents | 1 | 2007 | 12 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1538 | 0.280 |
Why?
|
| Animals | 9 | 2022 | 19661 | 0.280 |
Why?
|
| Bone Density | 1 | 2008 | 173 | 0.280 |
Why?
|
| Eicosanoic Acids | 1 | 2005 | 3 | 0.250 |
Why?
|
| Adipose Tissue | 1 | 2007 | 283 | 0.240 |
Why?
|
| Anticarcinogenic Agents | 1 | 2005 | 77 | 0.230 |
Why?
|
| 3T3-L1 Cells | 2 | 2014 | 83 | 0.220 |
Why?
|
| Triglycerides | 2 | 2019 | 242 | 0.200 |
Why?
|
| Membrane Potentials | 1 | 2022 | 136 | 0.190 |
Why?
|
| Eating | 3 | 2007 | 139 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2022 | 205 | 0.170 |
Why?
|
| Mice | 5 | 2014 | 10280 | 0.170 |
Why?
|
| Mice, Inbred ICR | 2 | 2008 | 27 | 0.150 |
Why?
|
| Random Allocation | 2 | 2007 | 199 | 0.130 |
Why?
|
| Neonicotinoids | 1 | 2012 | 1 | 0.110 |
Why?
|
| Diet | 2 | 2008 | 635 | 0.100 |
Why?
|
| Glucose | 1 | 2014 | 444 | 0.090 |
Why?
|
| Biomarkers | 1 | 2014 | 1210 | 0.080 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2007 | 24 | 0.070 |
Why?
|
| Humans | 3 | 2022 | 59517 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1295 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 576 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2008 | 247 | 0.060 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 52 | 0.060 |
Why?
|
| Microsomes, Liver | 1 | 2005 | 18 | 0.060 |
Why?
|
| Proteinuria | 1 | 2005 | 37 | 0.060 |
Why?
|
| Lipoprotein Lipase | 1 | 2005 | 15 | 0.060 |
Why?
|
| Glycerol | 1 | 2005 | 30 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 161 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 62 | 0.060 |
Why?
|
| Longevity | 1 | 2005 | 111 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2005 | 344 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2005 | 204 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 395 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2005 | 471 | 0.050 |
Why?
|
| Male | 3 | 2008 | 27572 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 735 | 0.050 |
Why?
|
| Female | 3 | 2008 | 30918 | 0.050 |
Why?
|
| Rats | 1 | 2005 | 1913 | 0.050 |
Why?
|
| Cell Line | 1 | 2005 | 2015 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2069 | 0.040 |
Why?
|